Their reasoning is backed by striking numbers. Across all Low Earth Orbit mega constellations, satellites pass dangerously close to one another with surprising frequency. A “close approach,” defined as two satellites coming within less than 1km of each other, happens about once every 22 seconds. Within the Starlink network alone, this occurs roughly every 11 minutes. To avoid collisions, each Starlink satellite must carry out an average of 41 course corrections every year.

When Rare Events Become Serious Risks

At first glance, this constant maneuvering might sound like proof that the system is working as intended. Engineers, however, know that failures often come from unusual situations rather than everyday operations. These rare scenarios, often called “edge cases,” can expose weaknesses that routine conditions never reveal. According to the study, solar storms are one such scenario that poses a serious threat to satellite mega constellations.

Solar storms typically disrupt satellites in two main ways.

How Solar Storms Disrupt Satellites

The first effect is atmospheric heating. When a solar storm hits Earth, it causes the upper atmosphere to expand and thicken, increasing drag on satellites. This added resistance forces satellites to burn more fuel just to stay in orbit and raises uncertainty about their precise positions. As a result, satellites must perform additional avoidance maneuvers to prevent collisions. During the “Gannon Storm” of May 2024 (which, unfortunately, appears not to be named after the Zelda villain), more than half of all satellites in LEO were forced to expend fuel on these adjustments.

The second effect can be even more damaging. Solar storms can interfere with or disable satellite navigation and communication systems altogether. When that happens, satellites may be unable to respond to threats in their path. Combined with higher atmospheric drag and increased uncertainty, this loss of control could quickly lead to a serious accident.

Measuring the Speed of Disaster

The most widely known outcome of widespread satellite collisions is Kessler syndrome. In this scenario, debris from collisions accumulates around Earth, making it nearly impossible to launch spacecraft without them being destroyed. While Kessler syndrome unfolds over decades, the researchers wanted to show how quickly a crisis could begin. To do this, they introduced a new measurement called the Collision Realization and Significant Harm (CRASH) Clock.

Using this metric, the authors calculated that as of June 2025, a complete loss of command over satellite avoidance maneuvers would result in a catastrophic collision in about 2.8 days. In contrast, similar conditions in 2018, before the rise of mega constellations, would have allowed roughly 121 days before such a collision occurred. The risk becomes even more alarming over shorter periods. Losing control for just 24 hours carries a 30% chance of a major collision that could kick off the long chain reaction leading to Kessler syndrome.

Little Warning and Few Options

One of the most troubling aspects of solar storms is how little notice they provide. In many cases, warnings come only a day or two in advance. Even with that notice, there are limited actions operators can take beyond trying to protect vulnerable systems. Solar storms create a rapidly changing atmospheric environment that requires constant, real time monitoring and control. If that real time control is lost, the paper suggests there may be only a few days to restore it before the entire system collapses.

This concern is not hypothetical. The 2024 Gannon Storm was the strongest solar storm in decades, but it was not the most powerful on record. That distinction belongs to the Carrington Event of 1859. If a storm of similar strength occurred today, it could disrupt satellite control for far longer than three days. A single event like this, which has already happened once in recorded history, could severely damage global satellite infrastructure and confine humanity to Earth for the foreseeable future.

Weighing the Risks of a Connected Sky

Few readers would welcome a future cut off from space. While satellite mega constellations offer enormous technological benefits, they also introduce serious long term risks. A realistic understanding of those dangers is essential. When the potential outcome includes losing access to space for generations due to one extreme solar storm, informed decision making becomes critical. This research provides a clearer picture of what is at stake and why the risks can no longer be ignored.

The earliest stars formed in regions dominated by dark matter, specifically at the centers of small dark matter structures called microhalos. Several hundred million light-years after the Big Bang, clouds made of hydrogen and helium cooled enough to begin collapsing under their own gravity. This process led to the birth of the first stars and marked the start of the cosmic dawn, a formative period in the universe’s history.

During this time, conditions may have allowed a rare type of star to form. These stars could be powered not only by nuclear fusion, but also by energy released when dark matter particles annihilate. Known as dark stars, such objects could grow to enormous sizes and may naturally evolve into the seeds that later become supermassive black holes.

JWST Reveals Unexpected Early Galaxies

JWST has now observed the most distant objects ever studied, offering an unprecedented look at the early universe. These observations have challenged long standing theories about how the first stars and galaxies formed. One of the most surprising findings is a large population of galaxies known as “blue monsters.” These galaxies are extremely bright, very compact, and contain little to no dust.

Before JWST, no simulations or theoretical models predicted that galaxies with these properties should exist so early in cosmic history. Their discovery has forced astronomers to reconsider how quickly stars and galaxies could have formed.

Overmassive Black Holes and Little Red Dots

JWST data have also intensified an ongoing mystery involving supermassive black holes. Some of the earliest observed galaxies appear to host black holes that are far larger than expected for their age. Explaining how the seeds of these larger-than-expected supermassive black holes (SMBHs) formed so quickly remains a major challenge.

In addition, JWST has revealed a new category of compact objects known as “little red dots” (LRDs). These dust-free sources date back to cosmic dawn and are unusual because they emit little to no X-ray radiation, something astronomers did not anticipate based on existing models.

Why Current Models Fall Short

Taken together, the blue monster galaxies, early overmassive black holes, and little red dots point to serious gaps in pre-JWST theories of early galaxy and black hole formation. The findings suggest that widely accepted models need substantial updates to account for what JWST is now seeing.

“Some of the most significant mysteries posed by the JWST’s cosmic dawn data are in fact features of the dark star theory,” Ilie said.

Growing Evidence for Dark Stars

Although dark stars have not yet been confirmed through direct observation, the new study strengthens the case for their existence. It builds on photometric and spectroscopic dark star candidates identified in two separate PNAS studies published in 2023 and 2025, respectively.

The authors describe in detail how dark stars could account for the properties of blue monster galaxies, little red dots, and early galaxies hosting massive black holes. The paper also presents the most recent spectroscopic analysis, reporting evidence for distinctive helium absorption features in the spectrum of JADES-GS-13-0. A similar feature had previously been identified in JADES-GS-14-0.

Why Dark Stars Matter

Dark stars are among the most intriguing theoretical objects in modern astrophysics. If confirmed, they could offer a way to directly probe the properties of dark matter particles. This would complement ongoing efforts to detect dark matter in laboratory experiments on Earth, whether through direct detection or particle production, and could help connect cosmic observations with fundamental physics.

This challenge has pushed researchers to look beyond the tumor itself and examine broader mechanisms of immune resistance. Scientists are increasingly focused on how cancers suppress immune activity throughout the body, not just at the tumor site. One emerging area of interest involves small extracellular vesicles (sEVs), tiny particles released by cancer cells that can carry immunosuppressive molecules and weaken the immune response in ways that are still not fully understood.

Investigating How PD-L1 Is Packaged and Released

To better understand this process, a research team from Fujita Health University in Japan, led by Professor Kunihiro Tsuchida, worked with collaborators from Tokyo Medical University Hospital and Tokyo Medical University. Their goal was to uncover how PD-L1, a key immune checkpoint protein, is selectively loaded into sEVs and to determine whether this pathway could be targeted therapeutically.

The study, published in Scientific Reports, was built around a central unanswered question. “Cancer cells release small extracellular vesicles containing PD-L1, which are thought to reduce the effectiveness of cancer immunotherapy. However, how PD-L1 is sorted into these vesicles has remained unclear.” Addressing this mystery became the foundation of the research.

A New Molecular Player in Immune Resistance

Using a wide range of techniques, including molecular and cell biology, biochemical and pharmacological tests, patient-derived samples, and bioinformatics, the researchers identified ubiquitin-like 3 (UBL3) as a key factor controlling how PD-L1 is directed into sEVs.

They found that PD-L1 undergoes a previously unknown post-translational modification involving UBL3. This modification occurs through a disulfide bond and differs from the classical process of ubiquitination. Further experiments showed that a specific amino acid, cysteine 272 in the cytoplasmic region of PD-L1, is essential for this modification.

When UBL3 levels were increased in cancer cells, the amount of PD-L1 packaged into sEVs rose sharply, even though total PD-L1 inside the cells remained unchanged. In contrast, reducing UBL3 levels led to a clear drop in PD-L1 being loaded into vesicles and released outside the cell. Together, these results confirmed that UBL3 plays a central role in directing PD-L1 into sEVs.

Statins Interfere With a Key Immune Escape Pathway

One of the most striking findings came when the team examined drugs that might interfere with this process. They discovered that statins, which are widely prescribed to lower cholesterol, strongly block UBL3 modification. All clinically used statins tested in the study reduced UBL3 activity, lowered PD-L1 modification, and sharply decreased the amount of PD-L1 sorted into sEVs.

These effects occurred at very low drug concentrations that are achievable in patients and were not linked to toxic effects on cells. Importantly, blood samples from people with non-small cell lung cancer showed a similar pattern. Among patients with high tumor PD-L1 expression, those taking statins had significantly lower levels of PD-L1-containing sEVs in their blood compared with patients not using statins.

Further bioinformatic analysis revealed that the combined expression of UBL3 and PD-L1 was associated with survival outcomes in lung cancer patients. This finding highlights the potential clinical importance of this newly identified regulatory pathway.

What This Means for Cancer Treatment

Taken together, these results help explain why immune checkpoint inhibitors often fail and point to a practical way to improve their performance. The study uncovers a hidden mechanism by which cancer cells spread immunosuppressive PD-L1 through extracellular vesicles, allowing tumors to weaken immune responses far beyond their immediate environment.

Linking this pathway to statins is especially important because these drugs are widely used, inexpensive, and generally safe. This raises the possibility that the findings could be translated into clinical practice relatively quickly. As the researchers note, “In the long term, this research may lead to more effective and accessible cancer immunotherapies. It could help more patients benefit from immune checkpoint treatments, improving survival and quality of life in real-world settings.”

A New Target for Overcoming Immunotherapy Resistance

In summary, the study shows that UBL3-driven modification promotes the packaging of PD-L1 into sEVs and that statins can disrupt this process, reducing levels of circulating immunosuppressive PD-L1. By identifying vesicle-associated PD-L1 trafficking as a modifiable driver of immune escape, the research opens a promising new path for tackling resistance to cancer immunotherapy. Adding statins to combination treatment strategies could offer a simple, scalable way to improve outcomes for patients receiving immune checkpoint inhibitors.